PharmaVoice Logo

Healthcare Leaders Hub

Can smarter technology selection help de-risk small-molecule development?

Pharma Tech

Can smarter technology selection help de-risk small-molecule development?

Predictive modelling for drug formulation helps developers select promising approaches and identify manufacturing challenges earlier.

Read Full Article
Top 20 Countries in Healthcare Innovation 2026 

PharmaShots

Top 20 Countries in Healthcare Innovation 2026 

Shots  Executive Summary  Healthcare-innovation capacity in 2026 is concentrated in small, research-dense health systems, while the world’s largest market still dominates clinical-research scale. PharmaShots scored 35 high-income and major emerging economies on five public indicators (health spending, physician supply, R&D intensity, researcher density and clinical-trial activity). Sweden (84.4), Austria (82.6), Switzerland (81.0), Denmark (75.8) and
 The post Top 20 Countries in Healthcare Innovation 2026  appeared first on PharmaShots.

Read Full Article
OrbiMed raises $3bn to back global life science players 

Pharma Tech

OrbiMed raises $3bn to back global life science players 

The duo of funds will support companies across the biopharma, healthcare technology, diagnostics and medical device disciplines.

Read Full Article
Cotecna Group acquires Energon Labs, strengthens global pharma testing capabilities

Express Pharma

Cotecna Group acquires Energon Labs, strengthens global pharma testing capabilities

The acquisition enhances Cotecna's ability to support both Indian and international  customers with high-quality and regulatory-compliant testing services  The post Cotecna Group acquires Energon Labs, strengthens global pharma testing capabilities appeared first on Express Pharma.

Read Full Article
AstraZeneca and insitro forge $1.5bn AI-powered cardiometabolic partnership 

Pharma Tech

AstraZeneca and insitro forge $1.5bn AI-powered cardiometabolic partnership 

This insitro deal sees AstraZeneca double down on its plans to enter the MASH market, which is expected to reach a value of $20.3bn in 2032.

Read Full Article

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

ET Pharma

Oct 18, 2026, 8:35 AM

Zydus to set up $20 million manufacturing facility in Sri Lanka

In its first phase, the facility will manufacture oral solid dosage forms for the Sri Lankan market and is projected to begun commercial operations in 2028.

ET Pharma

Oct 18, 2026, 5:29 AM

The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reach

The high cost of cancer drugs is in full public glare after the Supreme Court criticised the massive markup in their prices. A bench of Justices Vikram Nath and Sandeep Mehta called it "broad daylight dacoity."

ET Pharma

Oct 17, 2026, 2:46 AM

FDA flags five observations at Zydus’ Moraiya plant

According to a stock exchange filing, the facility was inspected from October 5 to 13.

ET Pharma

Oct 17, 2026, 2:32 AM

Indian, German firms to collaborate on immunoglobulin products: Indian Embassy

The Indian mission facilitated the exchange of a non-disclosure agreement (NDA) between Germany's Neovii Biotech GmbH and India's VINS Bioproducts Ltd on the sidelines of the Indo-German Health Leadership Dialogue on October 13, it said.

PharmaShots

Oct 16, 2026, 4:41 PM

Ascendis Pharma’s TransCon CNP (Navepegritide) Receives the CHMP’s Positive Opinion for Achondroplasia in Children

Shots: The CHMP has adopted a positive opinion recommending EU marketing authorization for Ascendis Pharma’s once-weekly TransCon CNP (navepegritide) for achondroplasia in children aged ≄2yrs. whose epiphyses are not closed; the EC decision on the MAA is expected in Q4’26 The opinion followed review of the MAA, incl. clinical data from 3 randomized, double-blind, PBO-controlled
 The post Ascendis Pharma’s TransCon CNP (Navepegritide) Receives the CHMP’s Positive Opinion for Achondroplasia in Children appeared first on PharmaShots.

PharmaShots

Oct 16, 2026, 4:38 PM

Sobi and Ionis’ Tryngolza (Olezarsen) Receives the CHMP’s Positive Opinion for Severe Hypertriglyceridemia (sHTG)

Shots: The CHMP has adopted a positive opinion recommending the indication extension of Sobi’s Tryngolza (olezarsen) as an adjunct to diet, in combination with other lipid-lowering therapies, for adults with severe hypertriglyceridemia (sHTG; fasting TG ≄880 mg/dL [≄10 mmol/L]); if confirmed, it would be the first & only RNA-targeted therapy authorised in the EU for
 The post Sobi and Ionis’ Tryngolza (Olezarsen) Receives the CHMP’s Positive Opinion for Severe Hypertriglyceridemia (sHTG) appeared first on PharmaShots.

News

Latest industry coverage

Google News

Oct 18, 2026, 9:00 PM

Europe turns to China as biotech partner while urging Korea to revamp funding - CHOSUNBIZ - Chosunbiz

Europe turns to China as biotech partner while urging Korea to revamp funding - CHOSUNBIZ  Chosunbiz

Google News

Oct 18, 2026, 7:31 PM

Laboratory Balances Market To 2035: Pharma R&D and Compliance Drive Forward Growth - News and Statistics - IndexBox

Laboratory Balances Market To 2035: Pharma R&D and Compliance Drive Forward Growth - News and Statistics  IndexBox

Google News

Oct 18, 2026, 6:36 PM

HPLC, UHPLC, And SFC Systems Market To 2035: Biologics Demand Accelerates Growth - News and Statistics - IndexBox

HPLC, UHPLC, And SFC Systems Market To 2035: Biologics Demand Accelerates Growth - News and Statistics  IndexBox

Google News

Oct 18, 2026, 6:24 PM

Pharma haircare market in India finds its growth roots in young patients - Business Standard

Pharma haircare market in India finds its growth roots in young patients  Business Standard

Google News

Oct 18, 2026, 6:11 PM

General Anesthesia Drugs Market Forecast to 2035, Driven by Aging Population and Surgical Volume Growth - IndexBox

General Anesthesia Drugs Market Forecast to 2035, Driven by Aging Population and Surgical Volume Growth  IndexBox

Google News

Oct 18, 2026, 4:43 PM

Amit Shah to meet families of Punjab drug-trade victims on Oct 19, vows crackdown on ‘chitta’ trade - The Times of India

Amit Shah to meet families of Punjab drug-trade victims on Oct 19, vows crackdown on ‘chitta’ trade  The Times of India

Google News

Oct 18, 2026, 4:42 PM

The next ayahuasca? Gabon fights to protect sacred plant from US drug companies - The Guardian

The next ayahuasca? Gabon fights to protect sacred plant from US drug companies  The Guardian

Google News

Oct 18, 2026, 4:15 PM

PatrĂłn co-founder bets $1M more on Miami biotech - The Business Journals

Patrón co-founder bets $1M more on Miami biotech  The Business Journals

Google News

Oct 18, 2026, 3:06 PM

Centre's cancer drug margin cap draws mixed response from industry, groups - Business Standard

Centre's cancer drug margin cap draws mixed response from industry, groups  Business Standard

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer